Exchange: NASDAQ·Updated 07:30 PM EST
ACET logo

ACET Adicet Bio Inc

$2.20
$0.32
(13.01%)
Today
Closed $2.14
$0.0618
(2.89%)
After Hours
Reported EarningsNov 5
Mkt Cap$20.03M
Vol765,205.00

About ACET

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
59

Bullish Sentiment

How do you feel about ACET?

BiotechValues
$ACET been building a big position again here at $25M market cap. Likely will need to do a strategic transaction (deal) in order to advance forward and obviously RA owns 10% too
2
AlexRo777
$ACET past month down -52.2% almost everyday new all time lows, since the reverse split this stock literally died, even with the upgrades and still dived every day
2
BioTechChap
$ACET Looking at this SP action one might think gamma delta caused patients to die. Unbelievable.
2
koreanseoul
$ACET If they decide to raise capital, the dilution will be severe, and given the typical post-offering decline, retail faces a high risk of total loss. For institutions, it’s much more advantageous to sit on the sidelines and participate directly in the upcoming raise once it becomes a certai
1
AlexRo777
$ACET th only stock that got upgraded by Webush and Wainwright and some other analysts and still went down over 50% in a month and few days
1
AlexRo777
$ACET it’s trading at 0.23$ before reverse split and it dropping to new all times lows everyday
1
Coolhat1
$ACET got out at huge loss after the pop last year from .70 to 1 dollar when they diluted right after good PR / data set I am so glad I was able to get out before the reverse split I did add on in low .60 too
1
focafoca99
$ACET begins its board reshuffle after a director resigns and a new audit committee chair is appointed.
charliemungo
$ACET "The investment decision could change depending on whether OrbiMed and RA lead the upcoming round and what the deal looks like. Even once the round is locked in, there will still be more than enough room to invest." time will tell
charliemungo
$ACET "The investment decision could change depending on whether OrbiMed and RA lead the upcoming round and what the deal looks like. Even once the round is locked in, there will still be more than enough room to invest."
Coolhat1
$ACET best thing to do is move and run for the hills I lost a decent amount in this there lead candidate is first in class car t with no other thing like it and very slim approval chance it’s almost out of money I revisit from time to time and can’t believe it’s back to 3 after reverse

Advertisement|Remove ads.